{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:11:51Z","timestamp":1786997511773,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009232","name":"University of Debrecen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","award":["FK128582"],"award-info":[{"award-number":["FK128582"]}],"id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00043"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00043"]}],"id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","award":["1Q4DBKX4STIP320"],"award-info":[{"award-number":["1Q4DBKX4STIP320"]}],"id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020916","name":"HUN-REN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020916","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.thromres.2023.12.004","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T17:57:21Z","timestamp":1702576641000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma"],"prefix":"10.1016","volume":"234","author":[{"given":"Harriet","family":"Ghansah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Orb\u00e1n-K\u00e1lm\u00e1ndi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildik\u00f3 Beke","family":"Debreceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9va","family":"Katona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Rejt\u0151","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"V\u00e1r\u00f3czy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"L\u00f3czi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"de Laat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Huskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Kappelmayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsa","family":"Bagoly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.thromres.2023.12.004_bb0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00277-016-2650-x","article-title":"Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias","volume":"95","author":"Dicke","year":"2016","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.thromres.2023.12.004_bb0010","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1182\/asheducation-2007.1.158","article-title":"Bleeding and thrombosis risks in plasma cell dyscrasias","author":"Eby","year":"2007","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"issue":"24","key":"10.1016\/j.thromres.2023.12.004_bb0015","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1182\/blood-2009-11-252072","article-title":"Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study","volume":"115","author":"Kristinsson","year":"2010","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2023.12.004_bb0020","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0049-3848(12)70024-5","article-title":"PL-17 risk and management of thrombosis in multiple myeloma","volume":"129","author":"Leebeek","year":"2012","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.004_bb0025","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1586\/14737140.7.3.307","article-title":"Thrombosis in multiple myeloma","volume":"7","author":"Zangari","year":"2007","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"9","key":"10.1016\/j.thromres.2023.12.004_bb0030","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1182\/blood-2008-04-151076","article-title":"Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"112","author":"Kristinsson","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2023.12.004_bb0035","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1600-0609.2010.01539.x","article-title":"Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism","volume":"86","author":"Gregersen","year":"2011","journal-title":"Eur. J. Haematol."},{"issue":"12","key":"10.1016\/j.thromres.2023.12.004_bb0040","first-page":"827","article-title":"Venous thromboembolism in patients with monoclonal Gammopathy of undetermined significance","volume":"7","author":"Alaa","year":"2009","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.004_bb0045","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/cncr.20405","article-title":"Monoclonal gammopathy of undetermined significance and multiple myeloma are associated with an increased incidence of venothromboembolic disease","volume":"101","author":"Srkalovic","year":"2004","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.thromres.2023.12.004_bb0050","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1093\/annonc\/mdh385","article-title":"The risk of venous thromboembolic disease in patients with monoclonal gammopathy of undetermined significance","volume":"15","author":"Sallah","year":"2004","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.004_bb0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0031-1273085","article-title":"Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis","volume":"37","author":"Zamagni","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"issue":"November 2022","key":"10.1016\/j.thromres.2023.12.004_bb0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.thromres.2023.01.010","article-title":"Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated protein C","volume":"223","author":"Ghansah","year":"2023","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.thromres.2023.12.004_bb0065","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3816\/CLM.2007.n.027","article-title":"Prothrombotic coagulation abnormalities in patients with paraprotein-producing B-cell disorders","volume":"7","author":"Auwerda","year":"2007","journal-title":"Clin. Lymphoma Myeloma"},{"issue":"3","key":"10.1016\/j.thromres.2023.12.004_bb0070","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1538-7836.2003.00083.x","article-title":"Extremely high levels of von willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment","volume":"1","author":"Minnema","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2023.12.004_bb0075","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.leukres.2007.12.002","article-title":"Prospective evaluation of coagulopathy in multiple myeloma patients before, during and after various chemotherapeutic regimens","volume":"32","author":"van Marion","year":"2008","journal-title":"Leuk. Res."},{"issue":"June","key":"10.1016\/j.thromres.2023.12.004_bb0080","first-page":"1","article-title":"Patients with multiple myeloma have a disbalanced whole blood thrombin generation profile","volume":"9","author":"Li","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.004_bb0085","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2004-08-3253","article-title":"Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis","volume":"105","author":"Lisman","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2023.12.004_bb0090","doi-asserted-by":"crossref","first-page":"0751","DOI":"10.1371\/journal.pmed.0050097","article-title":"Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis","volume":"5","author":"Meltzer","year":"2008","journal-title":"PLoS Med."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.004_bb0095","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/eci.12269","article-title":"Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma","volume":"44","author":"Undas","year":"2014","journal-title":"Eur. J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.004_bb0100","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-2143(96)90116-X","article-title":"Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma","volume":"128","author":"Carr","year":"1996","journal-title":"J. Lab. Clin. Med."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.004_bb0105","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1055\/s-0037-1615590","article-title":"Hypofibronolysis during induction treatment of multiple myeloma may increase the risk of venous thrombosis [3]","volume":"94","author":"van Marion","year":"2005","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2023.12.004_bb0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1182\/blood.V23.5.669.669","article-title":"Plasma fibrin stabilizing factor activity in various diseases","volume":"23","author":"Nussbaum","year":"1964","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.12.004_bb0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/VHRM.S240500","article-title":"Clinical significance of factor XIII activity and monocyte-derived microparticles in cancer patients","volume":"16","author":"Sawai","year":"2020","journal-title":"Vasc. Health Risk Manag."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.004_bb0120","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1600-0609.1981.tb00481.x","article-title":"Incomplete fibrin formation and highly elevated factor XIII activity in multiple myeloma","volume":"27","author":"Klingemann","year":"1981","journal-title":"Scand. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.004_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.1067","article-title":"Clinical and pathologic findings in 52 consecutively autopsied cases with multiple myeloma","volume":"67","author":"Oshima","year":"2001","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.thromres.2023.12.004_bb0130","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1182\/blood.V35.5.695.695","article-title":"Hemostatic defects in dysproteinemias","volume":"35","author":"Perkins","year":"1970","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2023.12.004_bb0135","first-page":"340","article-title":"Hemorrhagic diathesis in multiple myeloma","volume":"72","author":"Wallace","year":"1984","journal-title":"Acta Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.004_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2478\/ahp-2019-0006","article-title":"Abnormal hemostasis screening tests leading to diagnosis of multiple myeloma","volume":"50","author":"Iwaniec","year":"2019","journal-title":"Acta Haematol. Pol."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.004_bb0145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1152\/physrev.00016.2010","article-title":"Factor XIII: a coagulation factor with multiple plasmatic and cellular functions","volume":"91","author":"Muszbek","year":"2011","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.004_bb0150","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.thromres.2011.11.040","article-title":"Factor XIII, clot structure, thrombosis","volume":"129","author":"Bagoly","year":"2012","journal-title":"Thromb. Res."},{"issue":"5","key":"10.1016\/j.thromres.2023.12.004_bb0155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MOH.0b013e3283497e3e","article-title":"Novel aspects of factor XIII deficiency","volume":"18","author":"Muszbek","year":"2011","journal-title":"Curr. Opin. Hematol."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.004_bb0160","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0036-1572326","article-title":"Diagnosis and management of congenital and acquired FXIII deficiencies","volume":"42","author":"Muszbek","year":"2016","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.thromres.2023.12.004_bb0165","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.transci.2018.10.013","article-title":"Acquired factor XIII deficiency: a review","volume":"57","author":"Yan","year":"2018","journal-title":"Transfus. Apher. Sci."},{"issue":"2","key":"10.1016\/j.thromres.2023.12.004_bb0170","doi-asserted-by":"crossref","first-page":"278","DOI":"10.5858\/arpa.2012-0639-RS","article-title":"Factor XIII: congenital deficiency factor XIII, acquired deficiency, factor XIII A-subunit, and factor XIII B-subunit","volume":"138","author":"Tahlan","year":"2014","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"12","key":"10.1016\/j.thromres.2023.12.004_bb0175","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International myeloma working group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"issue":"15","key":"10.1016\/j.thromres.2023.12.004_bb0180","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.thromres.2023.12.004_bb0185","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/01.ATV.19.8.2012","article-title":"Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals: relation to sex, age, smoking, and hypertension","volume":"19","author":"Ari\u00ebns","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"25","key":"10.1016\/j.thromres.2023.12.004_bb0190","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","author":"Ward","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2023.12.004_bb0195","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0037-1613798","article-title":"A simple, quick one-step ELISA assay for the determination of complex plasma factor XII (A2B2)","volume":"83","author":"Katona","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2023.12.004_bb0200","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1182\/blood-2008-09-179333","article-title":"Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency","volume":"113","author":"Ajzner","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2023.12.004_bb0205","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s11239-020-02272-8","article-title":"Functional testing of tranexamic acid effects in patients undergoing elective orthopaedic surgery","volume":"51","author":"Groene","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"issue":"3","key":"10.1016\/j.thromres.2023.12.004_bb0210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/anae.15254","article-title":"A prospective observational study of the rapid detection of clinically-relevant plasma direct oral anticoagulant levels following acute traumatic injury","volume":"76","author":"Oberladst\u00e4tter","year":"2021","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1016\/j.thromres.2023.12.004_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-92041-1","article-title":"A modified in vitro clot lysis assay predicts outcomes and safety in acute ischemic stroke patients undergoing intravenous thrombolysis","volume":"11","author":"Orb\u00e1n-K\u00e1lm\u00e1ndi","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.thromres.2023.12.004_bb0220","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/jth.13656","article-title":"Development of Shiny app tools to simplify and standardize the analysis of hemostasis assay data: communication from the SSC of the ISTH","volume":"15","author":"Longstaff","year":"2017","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2023.12.004_bb0225","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/jth.15114","article-title":"Application of a plasmin generation assay to define pharmacodynamic effects of tranexamic acid in women undergoing cesarean delivery","volume":"19","author":"Miszta","year":"2021","journal-title":"J. Thromb. Haemost."},{"issue":"12","key":"10.1016\/j.thromres.2023.12.004_bb0230","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1055\/a-1450-8414","article-title":"COVID-19 is associated with an acquired factor XIII deficiency","volume":"121","author":"Von Meijenfeldt","year":"2021","journal-title":"Thromb. Haemost."},{"issue":"Supplement 1","key":"10.1016\/j.thromres.2023.12.004_bb0235","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2022-170330","article-title":"Acquired factor XIII deficiency is associated with high morbidity and mortality in critically ill patients","volume":"140","author":"L\u00f3pez Esteban","year":"2022","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2023.12.004_bb0240","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.3324\/haematol.2013.089045","article-title":"Hyperfibrinolysis and acquired factor XIII deficiency in newly diagnosed pediatric malignancies","volume":"98","author":"Wiegering","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.thromres.2023.12.004_bb0245","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1258\/cr.2009.090028","article-title":"Hyperfibrinolysis - is it common? Measurement and treatment including the role of thromboelastography","volume":"15","author":"Carey","year":"2009","journal-title":"Clin. Risk"},{"issue":"1","key":"10.1016\/j.thromres.2023.12.004_bb0250","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/hemato3010016","article-title":"Treatment resistance risk in patients with newly diagnosed multiple myeloma is associated with blood hypercoagulability: the ROADMAP-MM study","volume":"3","author":"Gerotziafas","year":"2022","journal-title":"Hemato"},{"issue":"2","key":"10.1016\/j.thromres.2023.12.004_bb0255","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/blood-2017-09-807560","article-title":"How i manage monoclonal gammopathy of undetermined significance","volume":"131","author":"Go","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.thromres.2023.12.004_bb0260","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1365-2141.2006.06208.x","article-title":"Acquired resistance to activated protein C (aAPCR) in multiple myeloma is a transitory abnormality associated with an increased risk of venous thromboembolism","volume":"134","author":"Elice","year":"2006","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.thromres.2023.12.004_bb0265","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11239-014-1140-z","article-title":"Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma","volume":"39","author":"Crowely","year":"2015","journal-title":"J. Thromb. Thrombolysis"},{"issue":"3","key":"10.1016\/j.thromres.2023.12.004_bb0270","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/bja\/aex122","article-title":"Assessment of standard laboratory tests and rotational thromboelastometry for the prediction of postoperative bleeding in liver transplantation","volume":"119","author":"D\u00f6tsch","year":"2017","journal-title":"Br. J. Anaesth."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.004_bb0275","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/vox.13225","article-title":"Viscoelastometric versus standard coagulation tests to guide periprocedural transfusion in adults with cirrhosis: a meta-analysis of randomized controlled trials","volume":"117","author":"Tangcheewinsirikul","year":"2022","journal-title":"Vox Sang."},{"issue":"4","key":"10.1016\/j.thromres.2023.12.004_bb0280","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.thromres.2014.01.011","article-title":"Assessment of rotation thromboelastometry (ROTEM) parameters in patients with multiple myeloma at diagnosis","volume":"133","author":"Treli\u0144ski","year":"2014","journal-title":"Thromb. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823003493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:26:13Z","timestamp":1777472773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823003493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":56,"alternative-id":["S0049384823003493"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.12.004","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}